Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Jason A. Keyes | Chief Financial Officer | 2022-12-09 | 4,444 | $1.19 | $5.29kBuy |
Joel Rothman | Chief Development Officer | 2022-12-09 | 3,821 | $1.19 | $4.55kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Decheng Capital Management Iii Cayman LLC | 12.66% | 4,447,308 | $2.70M | Institution |
Daniel Bradbury | 10.57% | 3,711,995 | $2.25M | Insider |
Bruce D. Steel | 10.57% | 3,711,995 | $2.25M | Insider |
Decheng Capital Global Life Sciences Fund Iv LP | 9.36% | 3,285,710 | $1.99M | Insider |
Sa Biocon | 6.60% | 2,316,134 | $1.41M | Insider |
Stephen Connelly | 2.83% | 993,000 | $602.75k | Insider |
Franklin Resources Inc | 2.55% | 895,000 | $543.27k | Institution |
Jpmorgan Chase Co | 2.49% | 873,609 | $530.28k | Institution |
Vanguard Group Inc | 2.38% | 836,930 | $508.02k | Institution |
Cota Capital Management LLC | 1.60% | 562,278 | $341.30k | Institution |